Up 26.73% pre-market 13 Mar 2026: Good Fellow Healthcare 8143.HK (HKSE) rally

We start pre-market on 13 Mar 2026 with 8143.HK stock up 26.73%, trading at HK$0.128 after a large volume spike of 1,580,000 shares. The move leads Hong Kong small-cap healthcare winners and follows higher intraday range, with a day low at HK$0.122 and day high at HK$0.135. Traders will watch liquidity and sector context, because the Healthcare sector is underperforming month-to-date, creating a short-term trade environment for momentum strategies.

Pre-market mover: 8143.HK stock performance

Good Fellow Healthcare Holdings Limited (8143.HK) is showing a clear pre-market gain of 26.73% on 13 Mar 2026. Price opened at HK$0.134, versus previous close HK$0.101, with intraday range HK$0.122–0.135. Market cap sits at HK$149,930,897.00, and shares outstanding are 1,127,299,976, which keeps float-sensitive moves possible.

Why shares jumped: volume, catalysts and sector context

Volume is the immediate catalyst: 1,580,000 shares traded versus average volume 1,153,059, a relative surge. The Healthcare sector in Hong Kong has seen weakness this month, which can amplify oversold rebounds in smaller medical care facilities names. No company-specific press release is listed in official feeds this morning, so we view this move as liquidity-driven and sentiment-sensitive, not earnings-driven.

Financials and valuation for 8143.HK stock

Good Fellow Healthcare reports EPS of -0.03 and a trailing PE of -4.43, reflecting losses. Key ratios show book value per share HK$0.01671 and price-to-book of 7.86. Revenue per share TTM is HK$0.02151, and free cash flow per share TTM is HK$0.00208. These metrics signal heavy valuation premiums relative to tangible equity, so investors should weigh growth expectations against weak profitability.

Technical picture and trading setup for 8143.HK stock

Technicals show a short-term momentum swing. RSI is 53.53, MACD neutral, and CCI at 131.17 suggests overbought conditions intraday. The 50-day average is HK$0.14256 and the 200-day average is HK$0.15496, both above the current price, so the rally remains below longer-term moving averages. Traders may prefer a tight stop given ATR HK$0.02 and thin liquidity risk on reversion.

Meyka AI rates 8143.HK with a score out of 100 and model forecast

Meyka AI rates 8143.HK with a score out of 100: total score 62.52, Grade B, Suggestion HOLD. This grade factors S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a quarterly price near HK$0.18, a monthly level near HK$0.12, and a year figure of HK$0.04880. Compared with current price HK$0.128, the quarterly projection implies an upside of 40.63%. Forecasts are model-based projections and not guarantees.

Risks, outlook and trading considerations for 8143.HK stock

Primary risks include negative earnings, thin float, and valuation disconnects. Net income per share TTM is -0.02259, return on equity is -5.74%, and interest coverage is weak at -70.11, all highlighting operational stress. On the upside, cash per share HK$0.00696 and a current ratio above 10.27 provide near-term liquidity buffer. We frame this as a tactical momentum trade, not a long-term value pick.

Final Thoughts

8143.HK stock is the top pre-market gainer on 13 Mar 2026 after a 26.73% jump on heavy volume of 1,580,000 shares. The move is driven by liquidity and momentum rather than fresh company guidance. Financials show negative EPS -0.03 and a price-to-book near 7.86, which raises valuation flags for buy-and-hold investors. Meyka AI’s model projects a near-term quarterly target of HK$0.18, implying 40.63% upside from HK$0.128, but the one-year model shows downside risk. Given the Healthcare sector softness and thin free float, we treat intraday strength as a short-term opportunity for traders who use tight risk controls. Meyka AI, our AI-powered market analysis platform, flags a Hold-grade profile and recommends position sizing that reflects liquidity and volatility risks. Forecasts are model-based and not guarantees, so confirm catalysts and liquidity before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.